vs

Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and MSCI Inc. (MSCI). Click either name above to swap in a different company.

MSCI Inc. is the larger business by last-quarter revenue ($822.5M vs $617.8M, roughly 1.3× Hims & Hers Health, Inc.). MSCI Inc. runs the higher net margin — 34.6% vs 3.3%, a 31.3% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 10.6%). MSCI Inc. produced more free cash flow last quarter ($488.7M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 10.0%).

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

MSCI Inc. is an American finance company headquartered in New York City. MSCI is a global provider of equity, fixed income, real estate indices, multi-asset portfolio analysis tools, ESG and climate finance products. It operates the MSCI World, MSCI Emerging Markets, and MSCI All Country World (ACWI) indices, among others.

HIMS vs MSCI — Head-to-Head

Bigger by revenue
MSCI
MSCI
1.3× larger
MSCI
$822.5M
$617.8M
HIMS
Growing faster (revenue YoY)
HIMS
HIMS
+17.8% gap
HIMS
28.4%
10.6%
MSCI
Higher net margin
MSCI
MSCI
31.3% more per $
MSCI
34.6%
3.3%
HIMS
More free cash flow
MSCI
MSCI
$491.2M more FCF
MSCI
$488.7M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
10.0%
MSCI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIMS
HIMS
MSCI
MSCI
Revenue
$617.8M
$822.5M
Net Profit
$20.6M
$284.7M
Gross Margin
71.9%
Operating Margin
1.5%
56.4%
Net Margin
3.3%
34.6%
Revenue YoY
28.4%
10.6%
Net Profit YoY
-20.8%
-6.8%
EPS (diluted)
$0.08
$3.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIMS
HIMS
MSCI
MSCI
Q4 25
$617.8M
$822.5M
Q3 25
$599.0M
$793.4M
Q2 25
$544.8M
$772.7M
Q1 25
$586.0M
$745.8M
Q4 24
$481.1M
$743.5M
Q3 24
$401.6M
$724.7M
Q2 24
$315.6M
$707.9M
Q1 24
$278.2M
$680.0M
Net Profit
HIMS
HIMS
MSCI
MSCI
Q4 25
$20.6M
$284.7M
Q3 25
$15.8M
$325.4M
Q2 25
$42.5M
$303.6M
Q1 25
$49.5M
$288.6M
Q4 24
$26.0M
$305.5M
Q3 24
$75.6M
$280.9M
Q2 24
$13.3M
$266.8M
Q1 24
$11.1M
$256.0M
Gross Margin
HIMS
HIMS
MSCI
MSCI
Q4 25
71.9%
Q3 25
73.8%
Q2 25
76.4%
Q1 25
73.5%
Q4 24
76.8%
Q3 24
79.2%
Q2 24
81.3%
Q1 24
82.4%
Operating Margin
HIMS
HIMS
MSCI
MSCI
Q4 25
1.5%
56.4%
Q3 25
2.0%
56.4%
Q2 25
4.9%
55.0%
Q1 25
9.9%
50.6%
Q4 24
3.9%
54.5%
Q3 24
5.6%
55.4%
Q2 24
3.5%
54.0%
Q1 24
3.6%
49.9%
Net Margin
HIMS
HIMS
MSCI
MSCI
Q4 25
3.3%
34.6%
Q3 25
2.6%
41.0%
Q2 25
7.8%
39.3%
Q1 25
8.4%
38.7%
Q4 24
5.4%
41.1%
Q3 24
18.8%
38.8%
Q2 24
4.2%
37.7%
Q1 24
4.0%
37.6%
EPS (diluted)
HIMS
HIMS
MSCI
MSCI
Q4 25
$0.08
$3.81
Q3 25
$0.06
$4.25
Q2 25
$0.17
$3.92
Q1 25
$0.20
$3.71
Q4 24
$0.10
$3.89
Q3 24
$0.32
$3.57
Q2 24
$0.06
$3.37
Q1 24
$0.05
$3.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIMS
HIMS
MSCI
MSCI
Cash + ST InvestmentsLiquidity on hand
$228.6M
$515.3M
Total DebtLower is stronger
$6.2B
Stockholders' EquityBook value
$540.9M
$-2.7B
Total Assets
$2.2B
$5.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIMS
HIMS
MSCI
MSCI
Q4 25
$228.6M
$515.3M
Q3 25
$345.8M
$400.1M
Q2 25
$1.1B
$347.3M
Q1 25
$273.7M
$360.7M
Q4 24
$220.6M
$409.4M
Q3 24
$165.5M
$501.0M
Q2 24
$129.3M
$451.4M
Q1 24
$105.2M
$519.3M
Total Debt
HIMS
HIMS
MSCI
MSCI
Q4 25
$6.2B
Q3 25
$5.5B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Q1 24
$4.5B
Stockholders' Equity
HIMS
HIMS
MSCI
MSCI
Q4 25
$540.9M
$-2.7B
Q3 25
$581.0M
$-1.9B
Q2 25
$562.7M
$-886.2M
Q1 25
$549.3M
$-958.6M
Q4 24
$476.7M
$-940.0M
Q3 24
$440.1M
$-751.0M
Q2 24
$362.0M
$-734.5M
Q1 24
$344.5M
$-650.5M
Total Assets
HIMS
HIMS
MSCI
MSCI
Q4 25
$2.2B
$5.7B
Q3 25
$2.2B
$5.4B
Q2 25
$1.9B
$5.4B
Q1 25
$891.7M
$5.3B
Q4 24
$707.5M
$5.4B
Q3 24
$602.3M
$5.4B
Q2 24
$480.5M
$5.5B
Q1 24
$448.1M
$5.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIMS
HIMS
MSCI
MSCI
Operating Cash FlowLast quarter
$61.3M
$501.1M
Free Cash FlowOCF − Capex
$-2.5M
$488.7M
FCF MarginFCF / Revenue
-0.4%
59.4%
Capex IntensityCapex / Revenue
10.3%
1.5%
Cash ConversionOCF / Net Profit
2.98×
1.76×
TTM Free Cash FlowTrailing 4 quarters
$57.4M
$1.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIMS
HIMS
MSCI
MSCI
Q4 25
$61.3M
$501.1M
Q3 25
$148.7M
$449.4M
Q2 25
$-19.1M
$336.1M
Q1 25
$109.1M
$301.7M
Q4 24
$86.4M
$430.6M
Q3 24
$85.3M
$421.6M
Q2 24
$53.6M
$349.2M
Q1 24
$25.8M
$300.1M
Free Cash Flow
HIMS
HIMS
MSCI
MSCI
Q4 25
$-2.5M
$488.7M
Q3 25
$79.3M
$445.5M
Q2 25
$-69.5M
$324.7M
Q1 25
$50.1M
$290.2M
Q4 24
$59.5M
$416.4M
Q3 24
$79.4M
$415.0M
Q2 24
$47.6M
$340.6M
Q1 24
$11.8M
$295.9M
FCF Margin
HIMS
HIMS
MSCI
MSCI
Q4 25
-0.4%
59.4%
Q3 25
13.2%
56.2%
Q2 25
-12.8%
42.0%
Q1 25
8.5%
38.9%
Q4 24
12.4%
56.0%
Q3 24
19.8%
57.3%
Q2 24
15.1%
48.1%
Q1 24
4.3%
43.5%
Capex Intensity
HIMS
HIMS
MSCI
MSCI
Q4 25
10.3%
1.5%
Q3 25
11.6%
0.5%
Q2 25
9.3%
1.5%
Q1 25
10.1%
1.5%
Q4 24
5.6%
1.9%
Q3 24
1.5%
0.9%
Q2 24
1.9%
1.2%
Q1 24
5.0%
0.6%
Cash Conversion
HIMS
HIMS
MSCI
MSCI
Q4 25
2.98×
1.76×
Q3 25
9.43×
1.38×
Q2 25
-0.45×
1.11×
Q1 25
2.20×
1.05×
Q4 24
3.32×
1.41×
Q3 24
1.13×
1.50×
Q2 24
4.03×
1.31×
Q1 24
2.32×
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIMS
HIMS

Segment breakdown not available.

MSCI
MSCI

Recurring Subscriptions$246.4M30%
Asset Based Fees$211.7M26%
Analytics Segment$182.3M22%
Sustainability And Climate Segment$90.3M11%
Other$70.9M9%
Non Recurring$21.1M3%

Related Comparisons